Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011	Dec. 31, 2010
REVENUES
Contract	$ 11,492	$ 195,408	$ 38,709	$ 411,555
Grant		846,768		846,768
Total revenues	11,492	1,042,176	38,709	1,258,323
Research and development	2,693,067	1,984,440	4,977,450	5,437,202
General and administrative	1,019,747	889,476	2,129,129	2,271,252
Total operating expenses	3,712,814	2,873,916	7,106,579	7,708,454
Loss from operations	(3,701,322)	(1,831,740)	(7,067,870)	(6,450,131)
Investment income	7,234	32,986	22,274	53,361
Interest expense	(1,847)	(1,329)	(4,820)	(3,633)
Gain on sale of securities		60,390		60,390
Gain on sale of supplies and equipment	3,000	1,800	3,000	1,800
Total other income, net	8,387	93,847	20,454	111,918
Loss before income taxes	(3,692,935)	(1,737,893)	(7,047,416)	(6,338,213)
Income tax benefit	1,068,233	637,391	1,068,233	637,391
NET LOSS	$ (2,624,702)	$ (1,100,502)	$ (5,979,183)	$ (5,700,822)
Basic and diluted net loss per common share	$ (0.08)	$ (0.09)	$ (0.17)	$ (0.48)
Weighted average number of common shares outstanding used in computing basic and diluted net loss per common share	34,900,591	11,839,309	34,900,591	11,785,470